SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Null hypothesis significance testing and effect sizes: can we 'effect' everything … or … anything?

Lovell, DP (2020) Null hypothesis significance testing and effect sizes: can we 'effect' everything … or … anything? Curr Opin Pharmacol, 51. pp. 68-77. ISSN 1471-4973 https://doi.org/10.1016/j.coph.2019.12.001
SGUL Authors: Lovell, David

[img] Microsoft Word (.docx) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (84kB)

Abstract

The Null Hypothesis Significance Testing (NHST) paradigm is increasingly criticized. Estimation approaches such as point estimates and confidence intervals, while having limitations, provide better descriptions of results than P-values and statements about significance levels. Their use is supported by many statisticians. The effect size approach is an important part of power and sample size calculations at the experimental design stage and in meta-analysis and in the interpretation of the biological importance of study results. Care is needed, however, to ensure that such effect sizes are relevant for the endpoint. Effect sizes should not be used to interpret results without accompanying limits, such as confidence intervals. New methods, especially Bayesian approaches, are being developed; however, no single method provides a simple answer. Rather there is a need to improve researchers understanding of the complex issues underlying experimental design, statistical analysis and interpretation of results.

Item Type: Article
Additional Information: © 2020. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Keywords: 1115 Pharmacology and Pharmaceutical Sciences, Pharmacology & Pharmacy
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Journal or Publication Title: Curr Opin Pharmacol
ISSN: 1471-4973
Language: eng
Dates:
DateEvent
April 2020Published
14 January 2020Published Online
6 December 2019Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
PubMed ID: 31948894
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/111649
Publisher's version: https://doi.org/10.1016/j.coph.2019.12.001

Actions (login required)

Edit Item Edit Item